Case Report: Transient Success Using Prolonged Treatment with Miltefosine for a Patient with Diffuse Cutaneous Leishmaniasis Infected with Leishmania mexicana mexicana

被引：13

作者：

Ordaz-Farias, Alejandro

Munoz-Garza, Fania Z.

Sevilla-Gonzalez, Farah K.

Arana-Guajardo, Ana

Ocampo-Candiani, Jorge

Trevino-Garza, Nancy ^{[1
]}

Becker, Ingeborg ^{[2
]}

Camacho-Ortiz, Adrian

机构：

[1] Natl Ctr Epidemiol Surveillance & Infect Control, Natl Vector Borne Dis Program, Mexico City, DF, Mexico

[2] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico

来源：

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2013年 / 88卷 / 01期

关键词：

MEGLUMINE ANTIMONIATE; NEW-WORLD; COMBINATION; CELLS; IMMUNOCHEMOTHERAPY; IMMUNOTHERAPY; THERAPY; TEXAS;

D O I：

10.4269/ajtmh.2012.11-0592

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Leishmania sp. is an intracellular parasite that causes a variable degree of clinical manifestations, especially in the skin. We present the case of a 38-year-old male with a chronic history of mucocutaneous disease present since childhood that generated deformity, loss of cartilage in the ears and nose, and scarring that limited his range of motion. The parasite was identified as L. mexicana mexicana. The patient was treated with a 3-month course of oral miltefosine with overwhelming results.

引用

页码：153 / 156

页数：4

共 23 条

[1] Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment [J].

Calvopina, Manuel ;

Gomez, Eduardo A. ;

Sindermann, Herbert ;

Cooper, Philip J. ;

Hashiguchi, Yoshihisa .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (06) :1074-1077

[2] CD8 Cells of Patients with Diffuse Cutaneous Leishmaniasis Display Functional Exhaustion: The Latter Is Reversed, In Vitro, by TLR2 Agonists [J].

Hernandez-Ruiz, Joselin ;

Salaiza-Suazo, Norma ;

Carrada, Georgina ;

Escoto, Sofia ;

Ruiz-Remigio, Adriana ;

Rosenstein, Yvonne ;

Zentella, Alejandro ;

Becker, Ingeborg .

PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (11)

[3]

Kashani MN, 2007, EUR J DERMATOL, V17, P513

[4]

Maroli M., 2004, Parassitologia (Rome), V46, P211

[5] Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment [J].

Mayrink, W ;

Botelho, ACD ;

Magalhaes, PA ;

Batista, SM ;

Lima, AD ;

Genaro, O ;

da Costa, CA ;

de Melo, MN ;

Michalick, MSM ;

Williams, P ;

Dias, M ;

Caiaffa, WT ;

do Nascimento, E ;

Machado-Coelho, GLL .

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2006, 39 (01) :14-21

[6] Cutaneous leishmaniasis in Texas [J].

McHugh, Chad P. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) :508-510

[7]

Meymandi SS, 2011, ARCH IRAN MED, V14, P238, DOI 0011144/AIM.003

[8]

Mondal S, 2010, EXPERT REV ANTI-INFE, V8, P919, DOI [10.1586/eri.10.78, 10.1586/ERI.10.78]

[9]

Nilforoushzadeh M. A., 2008, Journal of Vector Borne Diseases, V45, P287

[10] Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature [J].

Okwor, I. ;

Uzonna, J. E. .

IMMUNOTHERAPY, 2009, 1 (05) :765-776

← 1 2 3 →